China Universal Asset Management Company’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AUPH
IA
CAMG
YIH
CPC
FHA
PFSRSONJ
JWS
PI
PR
China Universal Asset Management Company's AUPH Position: Q2 2026 in Review
China Universal Asset Management Company reduced its Aurinia Pharmaceuticals (AUPH) stake by 13% in Q2 2026, selling an estimated $50K and leaving 20,467 shares worth $347K. The position accounts for 0.02% of the portfolio, ranked #299.
China Universal Asset Management Company first reported a position in AUPH in Q3 2022 and has held it in 16 quarters since. The position peaked at $350K in Q1 2026. 45 funds tracked by Wall St. Rank hold AUPH as of Q2 2026.
- China Universal Asset Management Company held 20,467 shares of Aurinia Pharmaceuticals worth $347K as of Q2 2026.
- China Universal Asset Management Company sold 3,130 Aurinia Pharmaceuticals shares in Q2 2026, an estimated $50K.
- Aurinia Pharmaceuticals made up 0.02% of China Universal Asset Management Company's portfolio in Q2 2026, its #299 holding.
- China Universal Asset Management Company first reported a position in Aurinia Pharmaceuticals in Q3 2022 and has held it in 16 quarters since.
- China Universal Asset Management Company's Aurinia Pharmaceuticals position peaked at $350K in Q1 2026.
- 45 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q2 2026.
Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.